Praxis Precision Medicines, Inc. Email Format

Biotechnology ResearchMassachusetts, United States201-500 Employees

Praxis Precision Medicines is a clinical-stage biotechnology company focused on central nervous system disorders characterized by neuronal imbalance. It translates genetic insights into therapies by targeting brain circuits involved in excitation and inhibition, pursuing treatments for both rare and more prevalent neurological conditions. The company advances discovery and development through proprietary platforms for small molecule therapies and antisense oligonucleotides.

Based in Boston, Massachusetts, Praxis operates in the CNS precision neuroscience space, developing medicines for patients and families affected by complex brain disorders. In June 2026, Praxis announced it would present a corporate overview at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, Florida.

Sign up for free to view info

Company overview Employee directory